adolescent health

Beyond the Daily Pill: The Dawn of Long-Acting HIV Treatment for Adolescents

By MedXY 02/19/2026

The IMPAACT 2017/MOCHA study reveals that long-acting injectable cabotegravir and rilpivirine administered every eight weeks is safe and highly effective for adolescents with HIV, potentially transforming the landscape of pediatric HIV care and adherence.

Diabetes & Endocrinology news Pediatrics

Delayed Puberty in Male Adolescents: A Novel Risk Factor for Early-Onset Type 2 Diabetes

By MedXY 01/30/2026

A nationwide cohort study of nearly 1 million Israeli males demonstrates that delayed puberty is independently associated with an increased risk of type 2 diabetes in early adulthood, suggesting it is a marker for long-term metabolic dysfunction.

news Urology

From Boyhood to Manhood: Recognizing and Addressing Pubertal Developmental Disorders

By MedXY 07/26/2025

Explore the science, warning signs, and practical advice on abnormal male puberty, bridging knowledge for families and clinicians.